Positive FDA feedback on our pivotal study for lead clinical candidate Bria-IMT™ in combination with ...
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...
BriaCell has received agreement and positive feedback from its End of Phase II meeting with ...
BriaCell’s new patent protects its novel personalized off-the-shelf cell-based technology for breast cancer and multiple ...
Accessibility Tools